Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination

Background: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function.Meth...

Full description

Bibliographic Details
Main Authors: Kaoru Sakatani, Katsunori Oyama, Lizhen Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.588140/full
_version_ 1818391861794963456
author Kaoru Sakatani
Kaoru Sakatani
Katsunori Oyama
Lizhen Hu
author_facet Kaoru Sakatani
Kaoru Sakatani
Katsunori Oyama
Lizhen Hu
author_sort Kaoru Sakatani
collection DOAJ
description Background: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function.Methods: We employed a deep neural network (DNN) to predict cognitive function based on subject's age and blood test items (23 items). We included 202 patients (73.48 ± 13.1 years) with various systemic metabolic disorders for training of the DNN model, and the following groups for validation of the model: (1) Patient group, 65 patients (73.6 ± 11.0 years) who were hospitalized for rehabilitation after stroke; (2) Healthy group, 37 subjects (62.0 ± 8.6 years); (3) Health examination group, 165 subjects (54.0 ± 8.6 years) admitted for a health examination. The subjects underwent the Mini-Mental State Examination (MMSE).Results: There were significant positive correlations between the predicted MMSE scores and ground truth scores in the Patient and Healthy groups (r = 0.66, p < 0.001). There were no significant differences between the predicted MMSE scores and ground truth scores in the Patient group (p > 0.05); however, in the Healthy group, the predicted MMSE scores were slightly, but significantly, lower than the ground truth scores (p < 0.05). In the Health examination group, the DNN model classified 94 subjects as normal (MMSE = 27–30), 67 subjects as having mild cognitive impairment (24–26), and four subjects as having dementia (≤ 23). In 37 subjects in the Health examination group, the predicted MMSE scores were slightly lower than the ground truth MMSE (p < 0.05). In contrast, in the subjects with neurological disorders, such as subarachnoid hemorrhage, the ground truth MMSE scores were lower than the predicted scores.Conclusions: The DNN model could predict cognitive function accurately. The predicted MMSE scores were significantly lower than the ground truth scores in the Healthy and Health examination groups, while there was no significant difference in the Patient group. We suggest that the difference between the predicted and ground truth MMSE scores was caused by changes in atherosclerosis with aging, and that applying the DNN model to younger subjects may predict future cognitive impairment after the onset of atherosclerosis.
first_indexed 2024-12-14T05:20:15Z
format Article
id doaj.art-871e84e293f647aa98afd0264443e141
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-14T05:20:15Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-871e84e293f647aa98afd0264443e1412022-12-21T23:15:41ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-12-011110.3389/fneur.2020.588140588140Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health ExaminationKaoru Sakatani0Kaoru Sakatani1Katsunori Oyama2Lizhen Hu3Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanInstitute for Healthcare Robotics, Future Robotic Organization, Waseda University, Tokyo, JapanDepartment of Computer Science, College of Engineering, Nihon University, Tokyo, JapanDepartment of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanBackground: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function.Methods: We employed a deep neural network (DNN) to predict cognitive function based on subject's age and blood test items (23 items). We included 202 patients (73.48 ± 13.1 years) with various systemic metabolic disorders for training of the DNN model, and the following groups for validation of the model: (1) Patient group, 65 patients (73.6 ± 11.0 years) who were hospitalized for rehabilitation after stroke; (2) Healthy group, 37 subjects (62.0 ± 8.6 years); (3) Health examination group, 165 subjects (54.0 ± 8.6 years) admitted for a health examination. The subjects underwent the Mini-Mental State Examination (MMSE).Results: There were significant positive correlations between the predicted MMSE scores and ground truth scores in the Patient and Healthy groups (r = 0.66, p < 0.001). There were no significant differences between the predicted MMSE scores and ground truth scores in the Patient group (p > 0.05); however, in the Healthy group, the predicted MMSE scores were slightly, but significantly, lower than the ground truth scores (p < 0.05). In the Health examination group, the DNN model classified 94 subjects as normal (MMSE = 27–30), 67 subjects as having mild cognitive impairment (24–26), and four subjects as having dementia (≤ 23). In 37 subjects in the Health examination group, the predicted MMSE scores were slightly lower than the ground truth MMSE (p < 0.05). In contrast, in the subjects with neurological disorders, such as subarachnoid hemorrhage, the ground truth MMSE scores were lower than the predicted scores.Conclusions: The DNN model could predict cognitive function accurately. The predicted MMSE scores were significantly lower than the ground truth scores in the Healthy and Health examination groups, while there was no significant difference in the Patient group. We suggest that the difference between the predicted and ground truth MMSE scores was caused by changes in atherosclerosis with aging, and that applying the DNN model to younger subjects may predict future cognitive impairment after the onset of atherosclerosis.https://www.frontiersin.org/articles/10.3389/fneur.2020.588140/fullAlzheimer's diseaseartificial intelligencedeep leaningdementiaMini Mental State Examinationscreening test
spellingShingle Kaoru Sakatani
Kaoru Sakatani
Katsunori Oyama
Lizhen Hu
Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
Frontiers in Neurology
Alzheimer's disease
artificial intelligence
deep leaning
dementia
Mini Mental State Examination
screening test
title Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_full Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_fullStr Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_full_unstemmed Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_short Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_sort deep learning based screening test for cognitive impairment using basic blood test data for health examination
topic Alzheimer's disease
artificial intelligence
deep leaning
dementia
Mini Mental State Examination
screening test
url https://www.frontiersin.org/articles/10.3389/fneur.2020.588140/full
work_keys_str_mv AT kaorusakatani deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination
AT kaorusakatani deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination
AT katsunorioyama deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination
AT lizhenhu deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination